Stock Research for VNDA

VNDA

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

VNDA Stock Chart & Research Data

The VNDA chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the VNDA chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


VNDA Due diligence Resources & Stock Charts

The VNDA stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View VNDA Detailed Price Forecast - CNN Money CNN View VNDA Detailed Summary - Google Finance
Yahoo View VNDA Detailed Summary - Yahoo! Finance Zacks View VNDA Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View VNDA Trends & Analysis - Trade-Ideas Barrons View VNDA Major Holders - Barrons
NASDAQ View VNDA Call Transcripts - NASDAQ Seeking View VNDA Breaking News & Analysis - Seeking Alpha
Spotlight View VNDA Annual Report - CompanySpotlight.com OTC Report View VNDA OTC Short Report - OTCShortReport.com
TradeKing View VNDA Fundamentals - TradeKing Charts View VNDA SEC Filings - Bar Chart
WSJ View Historical Prices for VNDA - The WSJ Morningstar View Performance/Total Return for VNDA - Morningstar
MarketWatch View the Analyst Estimates for VNDA - MarketWatch CNBC View the Earnings History for VNDA - CNBC
StockMarketWatch View the VNDA Earnings - StockMarketWatch MacroAxis View VNDA Buy or Sell Recommendations - MacroAxis
Bullish View the VNDA Bullish Patterns - American Bulls Short Pains View VNDA Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View VNDA Stock Mentions - StockTwits PennyStocks View VNDA Stock Mentions - PennyStockTweets
Twitter View VNDA Stock Mentions - Twitter Invest Hub View VNDA Investment Forum News - Investor Hub
Yahoo View VNDA Stock Mentions - Yahoo! Message Board Seeking Alpha View VNDA Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for VNDA - SECform4.com Insider Cow View Insider Transactions for VNDA - Insider Cow
CNBC View VNDA Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for VNDA - OTC Markets
Yahoo View Insider Transactions for VNDA - Yahoo! Finance NASDAQ View Institutional Holdings for VNDA - NASDAQ


Stock Charts

FinViz View VNDA Stock Insight & Charts - FinViz.com StockCharts View VNDA Investment Charts - StockCharts.com
BarChart View VNDA Stock Overview & Charts - BarChart Trading View View VNDA User Generated Charts - Trading View




Latest Financial News for VNDA


UPDATE 1-Shareholder Capital asks Vanda Pharma's board to reconsider Future Pak's offer
Posted on Thursday April 25, 2024

Investment firm Shareholder Capital sent a letter to drugmaker Vanda Pharmaceuticals' board on Thursday asking it to reconsider Future Pak's takeover offer. Last week, Vanda rejected contract manufacturer Future Pak's offer of $7.25 to $7.75 per share in cash, which represents a 59%-70% premium to Wednesday's closing price, and adopted a shareholder rights plan to avert a hostile takeover attempt. Shareholder Capital, which owns 200,000 outstanding shares of Vanda, asked in its letter, "on what basis did the Board reject Future Pak's offer, which values Vanda shares at nearly 2x their unaffected price."


Shareholder Capital Delivers Letter to Independent Members of the Board of Vanda Pharmaceuticals
Posted on Thursday April 25, 2024

Reminds Vanda’s Board of Their Fiduciary Duties Given the Mishandling of Future Pak’s Offer to Acquire Vanda’s Underperforming and Undervalued Shares at an ~80-90% Premium Expresses Serious Concerns Over Entrenchment, Misaligned Incentives, and Cronyism at Vanda, Including the CEO’s and His Family’s $46M+ in Disclosed Compensation Amidst $1B+ in Shareholder Value Destruction Believes Vanda’s Board Must Explore Strategic Alternatives MIAMI, April 25, 2024 (GLOBE NEWSWIRE) -- Shareholder Capital L


Vanda Pharmaceuticals (VNDA) Stock Sinks As Market Gains: What You Should Know
Posted on Wednesday April 24, 2024

Vanda Pharmaceuticals (VNDA) reachead $4.56 at the closing of the latest trading day, reflecting a -1.51% change compared to its last close.


Vanda (VNDA) to Report Q1 Earnings: What's in the Cards?
Posted on Wednesday April 24, 2024

On Vanda's (VNDA) first-quarter 2024 earnings call, investors' focus is likely to be on the sales performance of its marketed drugs and certain pipeline and regulatory updates.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.